Josh Gottheimer purchased BCRX (BioCryst Pharmaceuticals Inc) on Oct 16, 2023 with an estimated value between $1,000 and $15,000. This trade was filed under joint. The stock is currently up 60.0% from the trade price.

Josh Gottheimer

Democrat· house

New Jersey

BCRX

BioCryst Pharmaceuticals Inc

Health Care

Trade Details

Transaction

Purchase

Trade Date

Oct 16, 2023(2 years ago)

Disclosed

Nov 13, 202328d gap

Owner

joint

Estimated Value

$1,000 – $15,000

Trade Price

$5.94

Price Today

$9.51

Return (if held)

+60.0%

Josh Gottheimer bought $BCRX at $5.94 on Oct 16, 2023

View all 2 trades on BCRX

Price Change Since Trade

+60.0%